GH Research (GHRS) Enterprise Value (2020 - 2025)
GH Research's (GHRS) quarterly Enterprise Value came in at -$246.3 million in Q4 2025, down 104.91% year-on-year from $5.0 billion in Q4 2024, and up 1.36% quarter-over-quarter from -$249.7 million in Q3 2025.
GH Research (GHRS) Enterprise Value (2020 - 2025) Analysis & Trends
GH Research's Enterprise Value history runs 6 years deep, the most recent figure standing at -$246.3 million for Q4 2025.
- On a quarterly basis, Enterprise Value fell 104.91% year-over-year to -$246.3 million in Q4 2025; TTM through Dec 2025 was -$246.3 million, a 104.91% decrease from a year earlier, with the FY2025 full-year figure at -$246.3 million, down 104.91% from the prior year.
- Enterprise Value improved to -$246.3 million in Q4 2025 per GHRS's latest filing, from -$249.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$120.2 million in Q4 2024 and bottomed at -$280.7 million in Q3 2021.
- The 5-year median for Enterprise Value is -$206.1 million (2022), against an average of -$200.6 million.
- Across the five-year window, Enterprise Value slumped 5535620.0% in 2021 and surged 44.76% in 2023, its largest moves.
- Year by year, Enterprise Value stood at -$276.8 million in 2021, then surged by 40.04% to -$166.0 million in 2022, then rose by 19.24% to -$134.0 million in 2023, then rose by 10.33% to -$120.2 million in 2024, then slumped by 104.91% to -$246.3 million in 2025.
- Per Business Quant, the three latest GHRS Enterprise Value figures stand at -$246.3 million (Q4 2025), -$249.7 million (Q3 2025), and -$253.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | GH Research | 1.65 Bn | 1.65 Bn | - | -246.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -246.25 Mn |
| Sep 30, 2025 | -249.65 Mn |
| Jun 30, 2025 | -253.87 Mn |
| Mar 31, 2025 | -257.51 Mn |
| Dec 31, 2024 | -120.18 Mn |
| Sep 30, 2024 | -122.58 Mn |
| Jun 30, 2024 | -129.10 Mn |
| Mar 31, 2024 | -128.83 Mn |
| Dec 31, 2023 | -134.02 Mn |
| Sep 30, 2023 | -141.93 Mn |
| Jun 30, 2023 | -151.62 Mn |
| Mar 31, 2023 | -159.14 Mn |
| Dec 31, 2022 | -165.96 Mn |
| Sep 30, 2022 | -256.94 Mn |
| Jun 30, 2022 | -265.38 Mn |
| Mar 31, 2022 | -270.75 Mn |
| Dec 31, 2021 | -276.79 Mn |
| Sep 30, 2021 | -280.75 Mn |
| Dec 31, 2020 | -5,000.00 |